Circumventing the immune response to adenovirus-mediated gene therapy

Gene Therapy

Volumn 3, Issue 2, 1996, Pages 154-162

  Kass Eisler, A ^a   Leinwand, L ^a   Gall, J ^b   Bloom, B ^a   Falck Pedersen, E ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Adenovirus; Gene therapy; Immune response; Tolerization

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTYPE;

ADENOVIRUSES, HUMAN; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DRUG ADMINISTRATION SCHEDULE; FIBROBLASTS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; IMMUNE TOLERANCE; LUNG; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RATS; RATS, SPRAGUE-DAWLEY;

ADENOVIRIDAE; ANIMALIA;

EID: 0029968305     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
2. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant alpha1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-134.
3. Ragot T et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361. 647-650.
4. Stratford-Pericaudet LD et al. Widespread and long-term gene transfer to mouse skeletel muscles and heart. J Clin Invest 1992; 90: 626-630.
5. Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781-784.
6. Stratford-Perricaudet LD et al. Evalutation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
7. Kass-Eisler A et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 1993; 90: 11498-11502.
8. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
9. Engelhardt JF et al. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196-6200.
10. Kass-Eisler A et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994; 1: 395-402.
11. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994, 91: 4407-4411.
12. La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
13. Bennett J et al. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Opthal and Vis Sci 1994; 35: 2535-2541.
14. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219-223.
15. Yang Y et al. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
16. Mullbacher A, Bellet AJD, Hla RT. The murine cellular immune response to adenovirus type 5. Immunol Cell Biol 1989; 67: 31-39.
17. Urbanelli D et al. C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation. Virology 1989; 173: 607-614.
18. Flint J, Shenk T. Adenovirus E1a protein: paradigm viral transactivator. Ann Rev Genet 1989; 23: 141-161.
19. Lee WS et al. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 1991; 67: 365-376.
20. Lillie JW, Green MR. Transcription activation by the adenovirus E1a protein. Nature 1989; 338: 39-44.
21. Moran E. Interaction of adenoviral proteins with pRB and p53. FASEB J 1993; 7: 880-885.
22. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424-429.
23. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 1979; 17: 683-689.
24. Yang Y et al. Inactivation of E2A in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Gen 1994; 7: 362-369.
25. Mullbacher A. Viral escape from immune recognition: multiple strategies of adenoviruses. Immunol Cell Biol 1992; 70: 59-63.
26. Wohlfart C. Neutralization of adenoviruses: kinetics, stoichiometry and mechanisms. J Virol 1988; 62: 2321-2328.
27. Ginsberg HS. The Adenoviruses. Plenum Press: New York, 1984.
28. Horowitz MS. Adenoviridae and their replication: adenoviruses. In: Fields BN, Knipe DM (eds). Virology. Raven Press, New York, 1990, pp 1679-1742.
29. Toogood CIA, Crompton J, Hay RT. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J Gen Virol 1992; 73: 1429-1435.
30. Logan J, Shenk T. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci USA 1984; 81: 3655-3659.
31. Ahmed R. T cell tolerance to viruses. Curr Opin Immunol 1991; 3: 476-479.
32. Jamieson BD, Ahmed R. T cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc Natl Acad Sci USA 1988; 85: 2265-2268.
33. Korstoff JM et al. Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic non-responsiveness. J Exp Med 1990; 172: 1765-1775.
34. Nevins JR. Definition and mapping of adenovirus-2 nuclear transcription. Meth Enzymol 1980; 65: 765-785.
35. Graham FR et al. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-72.
36. Volkert FC, Young CSH. The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. Virology 1983, 125: 175-193.
37. Kitisis RN et al. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991; 88: 4138-4142.